丙型肝炎同伴教育者的感知益处：一项定性研究。
Perceived benefits of the hepatitis C peer educators: a qualitative investigation.
机构信息
Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY, 10467, USA.
Behavioral Medicine, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, One Bowdoin Square, 7th Floor, Boston, MA, 02114, USA.
出版信息
Harm Reduct J. 2017 Sep 29;14(1):67. doi: 10.1186/s12954-017-0192-8.
BACKGROUND
Although opioid-dependent patients are disproportionately impacted by hepatitis C (HCV), many do not receive treatment. In addition to HCV treatment-access barriers, substance-using patients may be reluctant to pursue treatment because of wariness of the medical system, lack of knowledge, or stigma related to HCV treatment. Implementation of a formal peer education program is one model of reducing provider- and patient-level barriers to HCV treatment, by enhancing mutual trust and reducing stigma.
METHODS
We used thematic qualitative analysis to explore how 30 HCV patients and peer educators perceived a HCV peer program within an established methadone maintenance program in the USA.
RESULTS
Participants unanimously described the program as beneficial. Participants described the peer educators' normalization and dispelling of myths and fears around HCV treatment, and their exemplification of HCV treatment success, and reductions in perceived stigma. Peer educators described personal benefits.
CONCLUSIONS
These findings indicate that HCV peer educators can enhance HCV treatment initiation and engagement within opioid substitution programs.
背景
尽管阿片类药物依赖患者受到丙型肝炎（HCV）的影响不成比例，但许多人并未接受治疗。除了 HCV 治疗的准入障碍外，药物使用者可能由于对医疗系统的警惕、缺乏知识或与 HCV 治疗相关的耻辱感而不愿意接受治疗。实施正式的同伴教育计划是减少 HCV 治疗提供者和患者层面障碍的一种模式，通过增强相互信任和减少耻辱感。
方法
我们使用主题定性分析来探讨 30 名 HCV 患者和同伴教育者如何看待美国一个既定美沙酮维持治疗计划中的 HCV 同伴项目。
结果
参与者一致认为该项目是有益的。参与者描述了同伴教育者对 HCV 治疗的正常化和消除误解和恐惧，以及他们对 HCV 治疗成功的示范，以及减少感知到的耻辱感。同伴教育者描述了个人的好处。
结论
这些发现表明，HCV 同伴教育者可以增强阿片类药物替代方案中 HCV 治疗的启动和参与。
Zotero 插件